tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrea Tan, 34 are a BUY (70.83%), 11 are a HOLD (22.92%), 3 are a SELL (6.25%).
Analyst Andrea Tan, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 46.31% that have a potential upside of 40.53% achieved within 182 days.
Andrea Tan’s has documented 94 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 18-Dec-2025.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for INSM (INSMED) at 5/15/2024. The price target of $49 was fulfilled within 14 days with a profit of $24.07 (96.55%) receiving and performance score of 68.96.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 01-Sep-2022
$1.4
$1.39 (13900.00%)
$2
3 years 2 months ago
(07-Nov-2022)
0/3 (0%)
$0.6 (75.00%)
Buy
Since 09-Nov-2020
$7
$6.99 (69900.00%)
$24
3 years 6 months 2 days ago
(05-Jul-2022)
2/6 (33.33%)
$4.12 (143.06%)
16
Which stock is Andrea Tan is most bullish on?
What Year was the first public recommendation made by Andrea Tan?
